Advertisement
08/05/2021

Amneal launches Taytulla generic Taysofy

Taytulla and its generic equivalents had a market value of roughly $124.4 million in the 12 months ended June 2021, according to IQVIA.
Sandra Levy
Senior Editor
Sandra Levy profile picture
text

Amneal is introducing norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules 1 mg/20 mcg, to be marketed as Taysofy.

The product is the generic of Abbvie's oral contraceptive brand Taytulla.

Taytulla and its generic equivalents had a market value of roughly $124.4 million in the 12 months ended June 2021, according to IQVIA.

Taysofye is packaged in cartons containing 5 unit-of-use 28-day blister packs. Each blister pack contains 24 days of active therapy and 4 days of ferrous fumarate supplements.

Advertisement
Advertisement